David Blum

David Blum has a diverse work experience in the biomedical industry. David started their career as a Senior Research and Development Engineer at Intelect Medical Inc. in 2007 and worked there until 2011. David then joined Boston Scientific, where they worked as a Senior Biomedical Systems Engineer from 2011 to 2018. During their tenure at Boston Scientific, they were promoted to the role of Principal Biomedical Engineer for a brief period in 2018. In 2018, they joined Qr8 Health as the Director of Research and Development. In 2019, they moved to CardioSolv Ablation Technologies, Inc. and held the position of Director of Product Development until 2022.

David Blum's education history begins in 2004 when they enrolled at Case Western Reserve University. David pursued a Bachelor of Science degree, with a major in Biomedical Engineering and a minor in Mathematics. David completed their undergraduate studies in 2008.

Afterwards, in 2009, David attended Boston University, where they pursued a Master of Science degree in Biomedical Engineering. David successfully completed their graduate studies in 2011.

Most recently, from 2021 to 2023, David joined the MIT Sloan School of Management to further enhance their academic qualifications. During this period, they worked towards obtaining an Executive MBA degree. The specific field of study for this degree was not provided in the information provided.